Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Common Equity (2017 - 2025)

Historic Common Equity for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $31.4 million.

  • Neuronetics' Common Equity rose 23429.27% to $31.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.4 million, marking a year-over-year increase of 23429.27%. This contributed to the annual value of $31.8 million for FY2024, which is 699.33% down from last year.
  • According to the latest figures from Q3 2025, Neuronetics' Common Equity is $31.4 million, which was up 23429.27% from $31.5 million recorded in Q2 2025.
  • Neuronetics' 5-year Common Equity high stood at $102.0 million for Q1 2021, and its period low was $9.4 million during Q3 2024.
  • Its 5-year average for Common Equity is $52.5 million, with a median of $45.5 million in 2023.
  • As far as peak fluctuations go, Neuronetics' Common Equity plummeted by 7527.48% in 2024, and later surged by 23429.27% in 2025.
  • Neuronetics' Common Equity (Quarter) stood at $85.2 million in 2021, then crashed by 33.01% to $57.1 million in 2022, then crashed by 40.08% to $34.2 million in 2023, then decreased by 6.99% to $31.8 million in 2024, then dropped by 1.38% to $31.4 million in 2025.
  • Its Common Equity stands at $31.4 million for Q3 2025, versus $31.5 million for Q2 2025 and $39.5 million for Q1 2025.